Specification of Drug Substances and Products 2013
DOI: 10.1016/b978-0-08-098350-9.01002-x
|View full text |Cite
|
Sign up to set email alerts
|

List of Contributors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…313 K in vacuo for ibuprofen, leaving small residual solvent concentrations adsorbed in the silica material. While these solvents have no therapeutic effect, they could be toxic and therefore should be avoided in the final product. ,,, The European Pharmacopoeia limits the concentration of residual solvents in pharmaceuticals, considering the guidelines compiled by the International Conference on Harmonization in the ICH guideline Q3C (EMA/CHMP/ICH/82260/2006). Tolerated concentrations of residual dichloromethane (DCM) and methanol (MeOH) are for example limited to 600 and 3000 ppm, respectively. ,,, …”
mentioning
confidence: 99%
“…313 K in vacuo for ibuprofen, leaving small residual solvent concentrations adsorbed in the silica material. While these solvents have no therapeutic effect, they could be toxic and therefore should be avoided in the final product. ,,, The European Pharmacopoeia limits the concentration of residual solvents in pharmaceuticals, considering the guidelines compiled by the International Conference on Harmonization in the ICH guideline Q3C (EMA/CHMP/ICH/82260/2006). Tolerated concentrations of residual dichloromethane (DCM) and methanol (MeOH) are for example limited to 600 and 3000 ppm, respectively. ,,, …”
mentioning
confidence: 99%